Keywords: biocryst/roche, psoriasis, drug, enters, ph, ii, alabama

BioCryst/Roche's psoriasis drug enters Ph II

Article | 23 July 2007

Print This

Alabama, USA-based BioCryst Pharmaceuticals and Swiss drug major Roche have initiated the first Phase II study to evaluate their co-developed ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in